Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenus
602
630
837
426
356
227
Croissance des revenus (H/H)
-1%
-25%
96%
20%
56.99%
11%
Coût des ventes
336
348
384
311
258
188
Bénéfice brut
265
281
453
115
97
39
Vente, Général et Administration
96
112
133
136
127
61
Recherche et développement
188
212
302
386
299
174
Frais d'exploitation
285
325
435
522
426
236
Autres revenus (charges) non opérationnels
41
5
1
-11
-10
4
Bénéfice avant impôts
535
45
105
-360
-155
-110
Charge d'impôt sur le revenu
67
7
4
0
11
4
Bénéfice net
466
37
100
-360
-194
-125
Croissance du bénéfice net
-1,237%
-63%
-128%
86%
55%
18%
Actions en circulation (diluées)
872.56
872.82
869.19
847.14
792.68
697.93
Variation des actions (H-H)
0%
0%
3%
7%
14%
5%
EPS (dilué)
0.53
0.04
0.11
-0.42
-0.24
-0.18
Croissance du EPS
-1,172%
-63%
-127%
73%
36%
13%
Flux de trésorerie libre
-59
-17
186
-305
-220
-81
Flux de trésorerie libre par action
--
--
--
--
--
--
Marge brute
44.01%
44.6%
54.12%
26.99%
27.24%
17.18%
Marge opérationnelle
-3.15%
-6.82%
2.15%
-95.53%
-92.13%
-86.34%
Marge bénéficiaire
77.4%
5.87%
11.94%
-84.5%
-54.49%
-55.06%
Marge du flux de trésorerie libre
-9.8%
-2.69%
22.22%
-71.59%
-61.79%
-35.68%
EBITDA
-7
-31
26
-399
-321
-190
Marge EBITDA
-1.16%
-4.92%
3.1%
-93.66%
-90.16%
-83.7%
D&A pour le résultat opérationnel
12
12
8
8
7
6
EBIT
-19
-43
18
-407
-328
-196
Marge EBIT
-3.15%
-6.82%
2.15%
-95.53%
-92.13%
-86.34%
Taux d'imposition effectif
12.52%
15.55%
3.8%
0%
-7.09%
-3.63%
Follow-Up Questions
Quels sont les états financiers clés de HUTCHMED (China) Limited ?
Quels sont les ratios financiers clés pour HCM ?
Comment les revenus de HUTCHMED (China) Limited sont-ils répartis par segment ou géographie ?
HUTCHMED (China) Limited est-elle rentable ?
HUTCHMED (China) Limited a-t-elle des passifs ?
Combien d'actions en circulation HUTCHMED (China) Limited a-t-elle ?
Statistiques clés
Clôture préc.
$14.75
Prix d'ouverture
$14.85
Plage de la journée
$14.76 - $14.85
Plage de 52 semaines
$11.5 - $19.5
Volume
5.3K
Volume moyen
37.1K
BPA (TTM)
2.65
Rendement en dividend
--
Capitalisation boursière
$2.5B
Qu’est-ce que HUTCHMED (China) Limited ?
HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. The company employs 1,780 full-time employees The company went IPO on 2006-05-19. The firm operates its business through two segments. Oncology Immunology segment is engaged in the discovery, development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Among it, research and development (R&D) includes research and development activities covering drug discovery, development, manufacturing and regulatory functions, out-licensing of in-house developed drugs, as well as administrative activities to support research and development operations, marketed products comprises the invoiced sales, marketing, manufacture and distribution of drugs developed from research and development activities. Other Ventures segment is engaged in the other commercial businesses which include the sales, marketing, manufacture and distribution of other prescription drugs and healthcare products.